Patterns of recurrence after trimodality therapy for esophageal cancer

Author： Dorth Jennifer A.   Pura John A.   Palta Manisha   Willett Christopher G.   Uronis Hope E.   D'Amico Thomas A.   Czito Brian G.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|14|2099-2105

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.14, 2014-07, pp. : 2099-2105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of PSA only Recurrence of Prostate Cancer After Prior Local Therapy

By  

Current Pharmaceutical Design, Vol. 12, Iss. 7, 2006-03 ,pp. : 785-798

Bentham Science Publishers

Access to resources Recommend Favorite

Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer

By McKay Rana R.   Gray Kathryn P.   Hayes Julia H.   Bubley Glenn J.   Rosenberg Jonathan E.   Hussain Arif   Kantoff Philip W.   Taplin Mary-Ellen  

Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. : 2603-2611

Blackwell Publishing

Access to resources Recommend Favorite

An expert opinion on esophageal cancer therapy

By Cohen Deirdre J   Ajani Jaffer  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 225-239

Informa Healthcare

Access to resources Recommend Favorite

Combined Modality Therapy of Esophageal Cancer

By Juergens Rosalyn A.   Forastiere Arlene  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 9, 2008-10 ,pp. : 851-861

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Epigenetic Aberrations and Targeted Epigenetic Therapy of Esophageal Cancer

By  

Current Cancer Drug Targets, Vol. 8, Iss. 6, 2008-01 ,pp. : 509-521

Bentham Science Publishers

Access to resources Recommend Favorite